VR Logo

Aurobindo Pharma: Board Meeting Intimation for To Consider The Standalone & Consolidated Unaudited Financial Results Of The Company For The First Quarter Ended June 30 2022


AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the Company will be held on Thursday August 11 2022 to consider and approve inter alia the Standalone & Consolidated Unaudited Financial Results of the Company for the first quarter ended June 30 2022.Further to our letter dated June 28 2022 informing the closure of Trading Window of the Company from July 1 2022 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the first quarter ended June 30 2022 we inform you that the Trading Window will remain closed up to August 13 2022 and shall be re-opened on August 14 2022.

Click here to view PDF